ST316

· Sapience Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST316, covering 2025-05-11 to 2025-05-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors [Phase 1]